MUTATIONS IN GENES ASSOCIATED WITH CLONAL HEMATOPOIESIS IN PATIENTS WITH ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
EHA Library, Anastasia Vasilieva, 4160449
HIGH IL7R DEFINES FAVORABLE T-ALL PROGNOSIS: CROSS-VALIDATION IN PEDIATRIC COHORTS
EHA Library, Senlin Zhang, 4160450
A RETROSPECTIVE STUDY OF RECIPIENT-DERIVED VERSUS DONOR-DERIVED CAR-T CELL THERAPY IN RELAPSED B-ALL PATIENTS AFTER TRANSPLANTATION
EHA Library, Lichao Liu, 4160451
PEGASPARGASE ADMINISTRATION IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS AGED 55 YEARS OR OLDER TREATED WITH THE PEDIATRIC-INSPIRED PROGRAM LAL1913. A SUBANALYSIS OF THE CAMPUS ALL STUDY
EHA Library, Davide Lazzarotto, 4160452
MULTICENTER REAL-WORLD STUDY ON INOTUZUMAB AS A BRIDGE TO CELLULAR THERAPY IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Alicia Aguirre, 4160453
CLINICAL EFFICACY ANALYSIS OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH EXTRAMEDULLARY DISEASE
EHA Library, Zhao defeng, 4160454
COMPARATIVE EFFICACY OF THE GIMEMA LAL1913 STANDARD CHEMOTHERAPY PROTOCOL VERSUS THE STANDARD ARM OF THE E1910 TRIAL IN MRD-NEGATIVE PH-NEGATIVE ALL: A MAIC ANALYSIS
EHA Library, Alfonso Piciocchi, 4160455
PROGNOSTIC SCORE MODELING FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Eduardo Chapchap, 4160456
RELAPSE RISK AND OUTCOME OF DISCONTINUING ASPARAGINASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, xingchen wang, 4160457
REAL WORLD DATA OF THE SAFETY AND EFFICACY OF TALICABTAGENE AUTOLEUCEL (HUMANIZED CD19 CAR-T) IN RELAPSED/REFRACTORY B-ACUTE LYMPHOBLASTIC LEUKEMIA FROM INDIA.
EHA Library, Hasmukh Jain, 4160458
T-ACUTE LYMPHOCYTIC LEUKEMIA: NEW PERSPECTIVES ON DIFFERENCES IN IMMUNOPHENOTYPES AND GENE PROFILES BETWEEN CHILDREN AND ADULTS
EHA Library, Siyu Liu, 4160459
DEFIBROTIDE TREATMENT OUTCOMES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) OCCURRING AFTER EXPOSURE TO INOTUZUMAB (INO) OR GEMTUZUMAB (GO)
EHA Library, Mohamad Mohty, 4160460
VENETOCLAX, TUCIDINOSTAT, PEGASPARGASE, AND DEXAMETHASONE INDUCTION REGIMEN FOR NEWLY DIAGNOSED ADULT ETP-ALL: A CHEMOTHERAPY-FREE, LOW-TOXICITY, EFFECTIVE REGIMEN
EHA Library, Jieping Lin, 4160462
EFFICACY AND SAFETY OF THE THIRD-GENERATION TYROSINE KINASE INHIBITOR OLVEREMBATINIB IN COMBINATION WITH INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH RELAPSED DISEASE OR PERSISTENT MINIMAL RESIDUAL DISEASE BRIDGING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PHASE II STUDY
EHA Library, Xiaoyu Zhang, 4160463
GENETIC CHARACTERISTICS OF BCR::ABL1-POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA WITH MULTILINEAGE INVOLVEMENT AND POST-HSCT SURVIVAL ANALYSIS
EHA Library, Tong Wang, 4160464
MRD-BASED TARGET THERAPY FOR PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS BY THE RALL-2016M PROTOCOL: EFFECTIVE FOR BCP-ALL, SHOWS NO EFFICACY IN T-ALL
EHA Library, Olga Aleshina Gavrilina, 4160465
CLINICAL ANALYSIS OF SEQUENTIAL CAR-T CELL THERAPY COMBINED WITH VENETOCLAX, HYPOMETHYLATING AGENTS, AND PERSONALIZED TARGETED DRUGS IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA
EHA Library, Zhao defeng, 4160466
PROGNOSTIC CLASSIFICATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: INTEGRATED ANALYSIS OF CLINICAL AND GENETIC FEATURES
EHA Library, Kana Kato, 4160467
REAL-WORLD OUTCOMES OF PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS TREATED WITH A PEDIATRIC-INSPIRED PROTOCOL: A COMPARISON ACROSS TWO TIME PERIODS
EHA Library, Maria Agustina Perusini, 4160468
COMBINATION OF VENETOCLAX AND DARATUMUMAB PLUS CAG REGIMEN IS AN EFFECTIVE TRANSPLANT BRIDGING REGIMEN IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSITIVE MINIMAL RESIDUAL DISEASE
EHA Library, Li-Jun Peng, 4160469
OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN STRATIFIED BY BODY MASS INDEX
EHA Library, Wendy Stock, 4160470
NOVEL EUROFLOW QUALITY ASSESSMENT ON B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA MINIMAL RESIDUAL DISEASE. PROGRAM DEVELOPMENT AND FOUR ROUNDS OF IMPLEMENTATION
EHA Library, Michaela Reiterová, 4160471
CO-OCCURRENCE OF CHILDHOOD ACUTE LEUKEMIA AND TYPE 1 DIABETES MELLITUS: A FINNISH CASE-CONTROL STUDY
EHA Library, Julia Ventelä, 4160473
TARGETING MUTANT TP53 ACUTE MYELOID LEUKEMIA THROUGH DISRUPTION OF MYC-GSPT1 AXIS
EHA Library, Michael Andreeff, 4160474
EPIGENETIC REGULATION OF ALDH1 BY ANTHRACYCLINES DRIVES CHEMORESISTANCE IN AML AND UNVEILS A THERAPEUTIC VULNERABILITY FOR CO-TARGETING WITH DNA METHYLATION INHIBITORS
EHA Library, Mileidys Perez, 4160475
TARGETING O-GLCNAC TRANSFERASE (OGT)-MEDIATED DRUG RESISTANCE IN INV(3)/T(3;3) AML
EHA Library, Junbum Im, 4160476
CHARACTERIZATION OF A NOVEL MOLECULAR DEPENDENCY IN HOXA9/MEIS1+ ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Federica Valigi, 4160477
TBK1-OPTN INTERACTION PROMOTES AML PROLIFERATION AND VENETOCLAX RESISTANCE BY ACTIVATING MITOPHAGY, TARGETED BY A NOVEL INHIBITOR PEPTIDE
EHA Library, Fan Niu, 4160478
GATA2 N-TERMINAL ZINC FINGER DOMAIN MUTATIONS PROMOTE ERYTHROID CLONAL EXPANSION IN ACUTE MYELOID LEUKEMIA
EHA Library, Tianhui Liu, 4160479
MAPPING LEUKEMIC STEM CELLS IN PEDIATRIC AML: A MULTIMODAL FRAMEWORK TO PRECISION TARGETING
EHA Library, sina kanannejad, 4160480
SINGLE-CELL DISSECTION OF SELF-DERIVED VERSUS DONOR-DERIVED T-CELL EXHAUSTION IN BONE MARROW NICHES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Chunzi Yu, 4160481
CXCR4 EXPRESSION IN AML BLASTS AND ITS IMPACT ON CXCR4 INHIBITOR EFFICACY DURING CONSOLIDATION THERAPY: RESULTS FROM THE SAL BLAST TRIAL
EHA Library, Enise Ceran, 4160482
MITOLEUK SCORE: MITOCHONDRIAL GENOME VARIANTS AS A PROGNOSTIC CLASSIFIER FOR ACUTE MYELOID LEUKEMIA COMPLEMENTARY TO EUROPEAN LEUKEMIANET CLASSIFICATION
EHA Library, Julie Mondet, 4160483
SINGLE-CELL PROFILING IDENTIFIES LEUKEMIC STEM CELL SUBTYPES LINKED TO ATRA SENSITIVITY IN RAS MUTANT ACUTE MYELOID LEUKEMIA
EHA Library, Diego A Pereira-Martins, 4160484
PEDIATRIC AML BLASTS PROMOTE AN IMMUNOSUPPRESSIVE M2-LIKE PHENOTYPE BY REPROGRAMMING MACROPHAGE METABOLISM.
EHA Library, Alicia Perzolli, 4160485
MICROBIOTA-INSPIRED COMPOUNDS AS NOVEL DRUG CANDIDATES TARGETING NPM1-MUTATED ACUTE MYELOID LEUKEMIA
EHA Library, Miguel Ángel Navarro Aguadero, 4160486
DEEP IMMUNOPHENOTYPING BY MASS CYTOMETRY ELUCIDATES THE PROGENITOR TRAJECTORY OF ERYTHROID-DERIVED ACUTE MYELOID LEUKEMIA
EHA Library, Inga KF Motzfeldt, 4160487
SYNERGISTIC EFFECTS OF PRL2 AND TKI CO-INHIBITION IN FLT3-MUTATED AND MLL-REARRANGED ACUTE MYELOID LEUKEMIA
EHA Library, Hongxia Chen, 4160488
CD180 IS A TARGETABLE MARKER FOR SENESCENCE ASSOCIATED CHEMORESISTANT IN PAEDIATRIC KMT2A-REARRANGED ACUTE MYELOID LEUKAEMIA
EHA Library, Aya Gouma, 4160489
DISRUPTING MITOCHONDRIAL FUNCTION IN ACUTE MYELOID LEUKEMIA: PERSONALIZED APPROACH TO THERAPEUTIC STRATEGY COMBINING BCL-2 INHIBITION WITH COMPLEX I BLOCKADE
EHA Library, Natalia Baran, 4160490
OXPHOS-DRIVEN M2-POLARIZED MACROPHAGES SUPPORT LEUKEMIC CELL GROWTH THROUGH MITOCHONDRIAL TRANSFER
EHA Library, Wendy Boschloo, 4160491
ONCOGENIC ASPP2K IN ACUTE MYELOID LEUKEMIA (AML): A POTENTIAL PREDICTIVE MARKER AND NOVEL THERAPEUTIC TARGET
EHA Library, Kerstin Kampa-Schittenhelm, 4160492
MANNOSE METABOLISM INHIBITION IS TOXIC TOWARDS ACUTE MYELOID LEUKAEMIA STEM CELLS WHILE SPARING NORMAL HAEMATOPOIETIC CELLS AT STEADY STATE.
EHA Library, Samantha Mason, 4160493
JAK2 R1063H GERMLINE VARIANT IN AML: ASSOCIATION WITH ONCOGENIC IDH1/2 DRIVERS RESULTING IN COOPERATIVE LEUKEMOGENESIS AND THERAPEUTIC IMPLICATIONS
EHA Library, Katarina Hlusickova Kapralova, 4160494
HIGH THROUGHPUT DRUG SCREEN COUPLED TO PROTEO-GENOMIC DATA IDENTIFIES EPIGENETIC VULNERABILITIES IN AML SUBTYPE-SPECIFIC PATIENT GROUP
EHA Library, Shanna Hogeling, 4160495
DRUG PERSISTENCE TO RESISTANCE EVOLUTION ANALYSIS IN HUMAN LEUKEMIA REVEALS DIVERSE LEUKEMIA-INITIATING CELL PHENOTYPES
EHA Library, Michael Milyavsky, 4160496
DECODING ACUTE MYELOID LEUKAEMIA: INTEGRATING FUNCTIONAL PHENOTYPES WITH GENOMICS
EHA Library, Prasad Iyer, 4160497
P16INK4A SUPPRESSION BY FLT3-ITD ENHANCES AML PROGRESSION: MECHANISTIC INSIGHTS AND THERAPEUTIC TARGETING OF EPIGENETIC REGULATORS
EHA Library, jiarui zheng, 4160498
IDENTIFICATION OF ELOVL6 AS A CAUSAL FACTOR AND POTENTIAL THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA
EHA Library, Linhui Hu, 4160499
RGT-61159, A POTENT AND SELECTIVE SMALL MOLECULE MYB RNA INHIBITOR, SHOWED SIGNIFICANT ANTI-TUMOR ACTIVITY AS MONOTHERAPY OR IN COMBINATION WITH STANDARDS OF CARE IN SEVERAL LEUKEMIA DISEASE MODELS HARBORING AML MOST COMMON GENETIC LESIONS
EHA Library, Patricia Soulard, 4160500
OVERCOMING AML HETEROGENEITY THROUGH MITOCHONDRIAL ACTIVITY AND AUTOPHAGY-INDUCED ENHANCEMENT OF AML CELLS BY BONE MARROW STROMAL CELLS
EHA Library, Shuqing Wang, 4160501
TARGETING DNA REPLICATION AND THE INTRA-S-PHASE CHECKPOINT FOR TREATMENT OF TP53-MUTATED AML
EHA Library, Sean Post, 4160502
ACTIVIN A INHIBITION IMPAIRED IN VITRO AML CELL MIGRATION AND IN VIVO BONE MARROW ENGRAFTMENT IN MICE
EHA Library, Blake Moses, 4160503
DIRECT FUNCTIONAL HOXA9/DNA BINDING COMPETITORS VERSUS EPIGENETIC INHIBITORS OF HOXA9 EXPRESSION ON CELL PROLIFERATION, DEATH AND DIFFERENTIATION PROCESSES IN THE MODEL OF MLL-REARRANGED ACUTE MYELOID LEUKAEMIA
EHA Library, Marie-Helene David-Cordonnier, 4160504
COMPLEMENTARITY OF HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE IN AML: A REAL LIFE STUDY FROM THE HAUTS-DE-FRANCE OBSERVATORY
EHA Library, Augustin Boudry, 4160505
THE TRANSCRIPTIONAL LANDSCAPE OF CLONAL AND MICROENVIRONMENT CELLS IN ACUTE MYELOID LEUKEMIA TREATED WITH HMA-VENETOCLAX AT SINGLE CELL LEVEL
EHA Library, Alfredo Marchetti, 4160506
TARGETING METABOLIC ALTERATIONS IN PML::RARα+ MYELOID CELLS TO OVERCOME RESISTANCE AND RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA.
EHA Library, Nelida I. Noguera, 4160507
GLUCOSE METABOLIC CHANGES DRIVE DISEASE PROGRESSION AND RELAPSE IN RUNX1::ETO ACUTE MYELOID LEUKEMIA
EHA Library, Nuria Tubio Santamaria, 4160508
IDENTIFICATION, EVALUATION AND IN VITRO VALIDATION OF IMMUNOGENIC NEOEPITOPES PREDICTED FROM ACUTE MYELOID LEUKEMIA (AML) BLASTS AFTER EXPOSURE TO SPLICING INHIBITOR DRUGS
EHA Library, Lady Espinosa, 4160509
HPK1 INHIBITOR BGB-15025 INDUCES APOPTOSIS IN AML CELLS THROUGH CELL CYCLE PATHWAY AND MAPK/ERK SIGNALING AXIS.
EHA Library, Shiyu Yang, 4160510
SINGLE-CELL IMMUNOMETABOLISM REVEALS A NOVEL PROGNOSTIC BIOMARKER IN ACUTE MYELOID LEUKEMIA AND UNCOVERS THE METABOLIC ROLE OF EXTRACELLULAR VESICLES
EHA Library, Dorian Forte, 4160511
INTEGRATIVE SYSTEMS BIOLOGY APPROACH UTILIZING TRANSCRIPTOMIC AND MUTATIONAL PROFILES TO UNVEIL PROGNOSIS-ASSOCIATED MOLECULAR PATHWAYS IN ACUTE MYELOID LEUKEMIA
EHA Library, Xiaoxue Wang, 4160512
INTERLEUKIN-8 IMPEDES MEGAKARYOCYTES PROPLATELET FORMATION VIA CXCR1/2-P38-NF-E2 SIGNAL AXIS LEADING TO THROMBOCYTOPENIA IN ACUTE MYELOID LEUKEMIA
EHA Library, Jing-li Han, 4160513
DEEP TARGETED SEQUENCING TO MONITOR MEASURABLE RESIDUAL DISEASE AND CHIMERISM IN MIELOID MALIGANCIES AFTER ALLOGENIC STEM CELL TRANSPLANT
EHA Library, Irene Zamanillo, 4160514
SELECTIVE THERAPEUTIC TARGETING ON MNX1-DRIVEN PROGRAMS IN INFANT AML
EHA Library, Ylenia Cicirò, 4160515
AVPR2-DRIVEN NEUROHYPOPHYSEAL DYSFUNCTION IN ADVERSE-RISK CYTOGENETIC AML: MECHANISTIC INSIGHTS AND SURVIVAL IMPLICATIONS
EHA Library, Diyaer Abuduaini, 4160516
WHOLE GENOME SEQUENCING REVEALS MULTI-DIMENSIONAL GENETIC ABERRATIONS AND CONTRIBUTES SIGNIFICANTLY TO ELN 2022 RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA
EHA Library, Guangxin Peng, 4160517
RAB37 ORCHESTRATES THE SREBP/SCD AXIS TO MODULATE LIPID METABOLISM AND DRIVE FERROPTOSIS RESISTANCE IN ACUTE MYELOID LEUKEMIA
EHA Library, Jishi Wang, 4160518
GUICAOBAIDU DECOCTION ALLEVIATES DOXORUBICIN-INDUCED MYOCARDIAL CARDIOTOXICITY VIA AMELIORATION OF TRDMT1/BNIP3 MEDIATED MITOPHAGY IN MICE
EHA Library, Xing Cui, 4160519
(LEUKEMIA-SPECIFC) B-CELLS IN AML PATIENTS CAN BE INDUCED BY IMMUNE MODULATORY THERAPY (KIT M: GM-CSF AND PGE-1) AND CONTRIBUTE TO IMPROVE ANTILEUKEMIC RESPONSE
EHA Library, Helga Schmetzer, 4160520
TRANSCRIPTOMIC AND CELLULAR DECONVOLUTION ANALYSIS REVEALS DISTINCT PROFILES ASSOCIATED WITH CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA
EHA Library, Alba Mora, 4160521
EXPLOITING TARGETED INHIBITION OF MASTL KINASE AS A NEW THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA
EHA Library, Sandra M Martin-Guerrero, 4160522
RIPK3 INDUCES APOPTOSIS IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA CELLS VIA REGULATION OF MFN2-MEDIATED MITOCHONDRIAL FUSION
EHA Library, yan zhang, 4160523
STUDY ON THE SYNTHETIC LETHAL MECHANISM OF SELECTIVE KILLING OF ALDH2 DEFICIENT ACUTE MYELOID LEUKEMIA CELLS BY INHIBITING BRIP1
EHA Library, Jishi Wang, 4160524
ADVANCING NK CELL IMMUNOTHERAPY IN AML AND OVERCOMING CYTOKINE-DRIVEN ADAPTIVE RESISTANCE
EHA Library, Monika Sponheimer, 4160525
MOLECULAR CHARACTERISTICS OF AML DEFINED BY DIFFERENTIATION
EHA Library, Christoph Kornauth, 4160526
FROM XENOGRAFT TO PATIENT: THE IMPACT OF SURFACE MARKERS ON AML EXTRAMEDULLARY INVASION
EHA Library, Matteo Caridi, 4160527
VENETOCLAX INDUCES MITOCHONDRIAL APOPTOSIS AND AUTOPHAGY TO OVERCOME ARSENIC TRIOXIDE RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Syed Hasan, 4160528
DELETERIOUS ROLE OF BYSTANDER CD8 T CELLS PRODUCING GRANZYME K IN ACUTE MYELOID LEUKEMIA PROGRESSION
EHA Library, Yannick Simoni, 4160529
PROGNOSTIC IMPACT OF FLT3-ITD LENGTH AND CLONAL PERSISTENCE IN MYELOID NEOPLASMS
EHA Library, Suresh Balasubramanian, 4160530
ANTI-LEUKEMIC ACTIVITY OF MITOTIC CHECKPOINT INHIBITOR BAL0891 AS MONOTHERAPY AND IN COMBINATION WITH TARGETED AGENTS
EHA Library, Mi Ji Choi, 4160531
CHARACTERISTICS AND PROGNOSTIC IMPACT OF IDH MUTATIONS IN A REAL-LIFE COHORT OF 217 PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Antonella Cucca, 4160532
SPHINGOSINE-1-PHOSPHATE (S1P) MODULATOR FTY720 SYNERGIZES WITH VENETOCLAX IN AML THROUGH MTOR PATHWAY SUPPRESSION, MITOCHONDRIAL DAMAGE, AND LYSOSOMAL STRESS INDUCTION
EHA Library, Katia Beider, 4160533
THZ1-INDUCED DNA DAMAGE TRIGGERS BOTH P53-DEPENDENT AND INDEPENDENT APOPTOSIS IN AML
EHA Library, Weidong Ding, 4160534
HOW AML MIGHT EXPLOIT RNA GRANULES FOR STRESS SHELTER, MORE THAN OTHER CANCERS.
EHA Library, Alessandro Pilli, 4160535
ACUTE MYELOID LEUKEMIA WITH 7Q DELETION: INCIDENCE, PROGNOSTIC, AND IMPACT ON RESPONSE TO BORTEZOMIB IN COMBINATION WITH AZACITIDINE OF EZH2 ALTERATIONS.
EHA Library, Iván Martín, 4160536
EXPLORATION OF MUTATIONAL PATTERNS AND THEIR IMPACT ON THE IMMUNE MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA THROUGH IN SILICO ANALYSES
EHA Library, Allana Carvalho, 4160537
ABNORMAL DNA DAMAGE RESPONSE SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MONOCYTIC LEUKEMIA POST TRANSPLANTATION
EHA Library, Yukun FENG, 4160538
A NEW ALGORITHM FOR HARMONIZING LARGE-SCALE RNA-SEQ INTEGRATION IN AML: ENABLING PLATFORM FOR DEEP ANALYSIS AND DISCOVERY
EHA Library, Matteo Caridi, 4160539
REGULATORY T CELL-PREDOMINANT TUMOR MICROENVIRONMENT (TME) PREDICTS POOR OUTCOMES IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN).
EHA Library, Claudia Tobar Cabrera, 4160540
PAEONIFLORIN TARGETING M6A RNA METHYLATION IMPROVES BNIP3 ASSOCIATE MITOPHAGY IN DOXORUBICIN-INDUCED MYOCARDIAL CARDIOTOXICITY
EHA Library, Xing Cui, 4160541
LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL-ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS
EHA Library, Talia Velasco-Hernandez, 4160542
PATIENTS WITH RELAPSED OR REFRACTORY (R/R) NUCLEOPHOSMIN 1-MUTATED (NPM1M) ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 2 AUGMENT-101 STUDY
EHA Library, Martha L Arellano, 4160543
VALIDATION OF THE EUROPEAN LEUKEMIANET 2024 RISK STRATIFICATION IN PATIENTS WITH NEWLY-DIAGNOSED AML TREATED WITH HMA+VEN: REAL-WORLD DATA BASED ON THE STUDY ALLIANCE LEUKEMIA AML REGISTRY
EHA Library, Lydia Kretschmer, 4160544
HYPOMETHYLANTS IN MONOTHERAPY OR COMBINED WITH VENETOCLAX: REAL-LIFE EXPERIENCE IN 1964 PATIENTS REPORTED TO THE PETHEMA-GPLA REGISTRY
EHA Library, Eliana Aguiar, 4160545
RISK STRATIFICATION OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX IN COMBINATION WITH INTENSIVE CHEMOTHERAPY
EHA Library, Wei-Ying Jen, 4160546
A PHASE IB/2 TRIAL OF AN ALL-ORAL „TRIPLET” REGIMEN FOR IDH-MUTATED MYELOID MALIGNANCIES: DECITABINE/CEDAZURIDINE AND VENETOCLAX IN COMBINATION WITH IVOSIDENIB/ENASIDENIB
EHA Library, Jennifer Marvin-Peek, 4160547
PROGNOSTIC VALUE OF MOLECULAR MEASURABLE RESIDUAL DISEASE MONITORED BY DIGITAL PCR BEFORE AND AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TP53-MUTATED AML/MDS COHORT: A TROPHY STUDY
EHA Library, Yanmin Zhao, 4160548
UPDATED RESULTS AND LONGER FOLLOW-UP FROM THE AUGMENT-101 PHASE 2 STUDY OF REVUMENIB IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) KMT2AR ACUTE LEUKEMIA
EHA Library, Ibrahim Aldoss, 4160549
CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES IN 405 ADULT PATIENTS WITH MIXED PHENOTYPE ACUTE LEUKEMIA: A STUDY FROM THE PETHEMA AND PALG GROUPS
EHA Library, Marta Sobas, 4160550

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings